These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21906831)

  • 1. GLP-1 agonist treatment: implications for diabetic retinopathy screening.
    Varadhan L; Humphreys T; Hariman C; Walker AB; Varughese GI
    Diabetes Res Clin Pract; 2011 Dec; 94(3):e68-71. PubMed ID: 21906831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New prospects in the treatment of diabetic retinopathy. Current situation and pharmacological developments].
    Lagrèze WA
    MMW Fortschr Med; 2003 Apr; 145(14):37-8. PubMed ID: 15072277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening and care of pregnancy in diabetics].
    Orv Hetil; 1993 May; 134(18):975-7. PubMed ID: 8483592
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetus mellitus and pregnancy].
    Neckell A; Munteanu M
    Oftalmologia; 2009; 53(3):118-22. PubMed ID: 19899558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diagnosis-time and initial treatment on the onset of type 2 diabetes mellitus complications: a population-based representative cross-sectional study in Hungary.
    Nagy A; Adany R; Sandor J
    Diabetes Res Clin Pract; 2011 Dec; 94(3):e65-7. PubMed ID: 21880389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus and pregnancy--the current status. II. Diabetes types 1 and 2, diabetic nephropathy and diabetic retinopathy. The effect of diabetes on pregnancy and of pregnancy on diabetes. Diagnostic monitoring].
    Katsulov A
    Akush Ginekol (Sofiia); 1989; 28(1):1-8. PubMed ID: 2662795
    [No Abstract]   [Full Text] [Related]  

  • 9. Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
    Rachman J; Barrow BA; Levy JC; Turner RC
    Diabetologia; 1997 Feb; 40(2):205-11. PubMed ID: 9049482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous subcutaneous insulin infusion].
    Araki H; Makino H; Yoshida S
    Nihon Rinsho; 1990 Dec; 48 Suppl():1038-43. PubMed ID: 2086865
    [No Abstract]   [Full Text] [Related]  

  • 11. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progression of diabetic retinopathy during pregnancy: a retrospective analysis of a series of 77 consecutive patients].
    Stalnikiewicz L; Floriot M; Guerci B; Angioi K
    J Fr Ophtalmol; 2010 Sep; 33(7):481-6. PubMed ID: 20674081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy in pregnancy: a review.
    Morrison JL; Hodgson LA; Lim LL; Al-Qureshi S
    Clin Exp Ophthalmol; 2016 May; 44(4):321-34. PubMed ID: 27062093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretins and other peptides in the treatment of diabetes.
    Todd JF; Bloom SR
    Diabet Med; 2007 Mar; 24(3):223-32. PubMed ID: 17263764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.
    Penfornis A; Borot S; Raccah D
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S78-90. PubMed ID: 18640590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type 1 diabetes.
    Ringholm L; Vestgaard M; Laugesen CS; Juul A; Damm P; Mathiesen ER
    Growth Horm IGF Res; 2011 Feb; 21(1):25-30. PubMed ID: 21212010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 agonists: improving the future of patients with type 2 diabetes.
    Shubrook JH
    J Am Osteopath Assoc; 2011 Feb; 111(2 Suppl 1):2 p preceding eS2. PubMed ID: 21409846
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes.
    Lugari R; Dell'Anna C; Ugolotti D; Dei Cas A; Barilli AL; Zandomeneghi R; Marani B; Iotti M; Orlandini A; Gnudi A
    Horm Metab Res; 2000 Oct; 32(10):424-8. PubMed ID: 11069208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.